We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBN:NASDAQNortheast Bank Analysis

Data as of 2026-07-05 - not real-time

$134.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Northeast Bank (NBN) is trading well above its short‑term moving average and comfortably above the medium‑term average, indicating sustained upward momentum. The 20‑day SMA sits higher than the 200‑day SMA, confirming a long‑term bullish trend. Momentum indicators are positive, with RSI in the upper half of its range and MACD generating a bullish crossover. Volume has remained stable, supporting the price advance without signs of exhaustion. The stock is priced near the upper end of its recent trading range but still offers modest upside to the consensus target. Fundamental data show revenue expanding at a rapid pace and operating margins well above industry averages, delivering strong profitability.
Valuation metrics point to a discount relative to peer banks, with a price‑to‑earnings multiple notably below the sector average. The dividend payout is minimal, leaving ample earnings to fund growth and maintain a healthy balance sheet. Leverage is modest, and the company holds a solid cash position that exceeds its debt obligations, reducing financial risk. The beta below one suggests lower volatility than the market, while the 30‑day price swings remain elevated, highlighting short‑term price risk. Overall, the combination of bullish technicals, strong earnings growth, and attractive valuation makes NBN a compelling candidate for investors seeking exposure to regional banking with limited downside. Investors should consider adding the stock on a medium‑ to long‑term horizon while monitoring near‑term price action around the identified resistance level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (RSI, MACD)
  • Price near resistance with limited upside
  • Stable volume supporting current levels

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • Undervalued relative to industry PE
  • Solid cash position and low leverage

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable earnings supporting dividend
  • Low beta indicating lower market volatility
  • Robust ROE and consistent profitability

Key Metrics & Analysis

Financial Health

Revenue Growth34.60%
Profit Margin42.71%
P/E Ratio11.6
ROE19.00%
ROA2.12%
P/B Ratio2.0
Op. Cash Flow$4.0M
Industry P/E17.5

Technical Analysis

TrendBullish
RSI62.3
Support$117.48
Resistance$142.31
MA 20$128.03
MA 50$124.86
MA 200$109.90
MACDBullish
VolumeStable
Fear & Greed Index93.2

Valuation

Target Price$136.50
Upside/Downside1.50%
GradeUndervalued
TypeGrowth
Dividend Yield0.03%

Risk Assessment

Beta0.92
Volatility31.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.